These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24144476)

  • 1. DNA vaccine expressing the non-structural proteins of hepatitis C virus diminishes the expression of HCV proteins in a mouse model.
    Wada T; Kohara M; Yasutomi Y
    Vaccine; 2013 Dec; 31(50):5968-74. PubMed ID: 24144476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
    Latimer B; Toporovski R; Yan J; Pankhong P; Morrow MP; Khan AS; Sardesai NY; Welles SL; Jacobson JM; Weiner DB; Kutzler MA
    Hum Vaccin Immunother; 2014; 10(8):2357-65. PubMed ID: 25424943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins.
    Pancholi P; Liu Q; Tricoche N; Zhang P; Perkus ME; Prince AM
    J Infect Dis; 2000 Jul; 182(1):18-27. PubMed ID: 10882577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
    Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
    J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Combination Vaccine, Comprising Bifidobacterium Displaying Hepatitis C Virus Nonstructural Protein 3 and Interferon-α, Induces Strong Cellular Immunity Specific to Nonstructural Protein 3 in Mice.
    Kitagawa K; Omoto C; Oda T; Araki A; Saito H; Shigemura K; Katayama T; Hotta H; Shirakawa T
    Viral Immunol; 2017 Apr; 30(3):196-203. PubMed ID: 28112593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice.
    Cao J; Chen Z; Ren Y; Luo Y; Cao M; Lu W; Zhao P; Qi Z
    Vaccine; 2011 May; 29(20):3714-23. PubMed ID: 21396407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity evaluation of a DNA vaccine expressing the hepatitis C virus non-structural protein 2 gene in C57BL/6 mice.
    Gorzin Z; Gorzin AA; Tabarraei A; Behnampour N; Irani S; Ghaemi A
    Iran Biomed J; 2014; 18(1):1-7. PubMed ID: 24375156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by an intrahepatic inoculation with an expression plasmid.
    Kamei A; Tamaki S; Taniyama H; Takamura S; Nishimura Y; Kagawa Y; Uno-Furuta S; Kaito M; Kim G; Toda M; Matsuura Y; Miyamura T; Adachi Y; Yasutomi Y
    Virology; 2000 Jul; 273(1):120-6. PubMed ID: 10891414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo clearance of hepatitis C virus nonstructural 3/4A-expressing hepatocytes by DNA vaccine-primed cytotoxic T lymphocytes.
    Ahlen G; Nystrom J; Pult I; Frelin L; Hultgren C; Sallberg M
    J Infect Dis; 2005 Dec; 192(12):2112-6. PubMed ID: 16288375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial.
    Alvarez-Lajonchere L; Shoukry NH; Grá B; Amador-Cañizares Y; Helle F; Bédard N; Guerra I; Drouin C; Dubuisson J; González-Horta EE; Martínez G; Marante J; Cinza Z; Castellanos M; Dueñas-Carrera S
    J Viral Hepat; 2009 Mar; 16(3):156-67. PubMed ID: 19017255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.
    Marín MQ; Pérez P; Ljungberg K; Sorzano CÓS; Gómez CE; Liljeström P; Esteban M; García-Arriaza J
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs.
    Tokushige K; Wakita T; Pachuk C; Moradpour D; Weiner DB; Zurawski VR; Wands JR
    Hepatology; 1996 Jul; 24(1):14-20. PubMed ID: 8707253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broadening CD4
    Filskov J; Mikkelsen M; Hansen PR; Christensen JP; Thomsen AR; Andersen P; Bukh J; Agger EM
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
    Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
    J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of chronic ethanol consumption on cellular immune responses to hepatitis C virus core protein are reversed by genetic immunizations augmented with cytokine-expressing plasmids.
    Geissler M; Gesien A; Wands JR
    J Immunol; 1997 Nov; 159(10):5107-13. PubMed ID: 9366440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCV-NS3 Th1 minigene vaccine based on invariant chain CLIP genetic substitution enhances CD4(+) Th1 cell responses in vivo.
    Gao M; Wang HP; Wang YN; Zhou Y; Wang QL
    Vaccine; 2006 Jun; 24(26):5491-7. PubMed ID: 16725235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses to hepatitis C virus structural and nonstructural proteins induced by plasmid DNA immunizations.
    Gordon EJ; Bhat R; Liu Q; Wang YF; Tackney C; Prince AM
    J Infect Dis; 2000 Jan; 181(1):42-50. PubMed ID: 10608749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.
    Gummow J; Li Y; Yu W; Garrod T; Wijesundara D; Brennan AJ; Mullick R; Voskoboinik I; Grubor-Bauk B; Gowans EJ
    J Virol; 2015 Aug; 89(15):7991-8002. PubMed ID: 26018154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
    Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant adenoviral vector expressing HCV NS4 induces protective immune responses in a mouse model of Vaccinia-HCV virus infection: a dose and route conundrum.
    Singh S; Vedi S; Li W; Samrat SK; Kumar R; Agrawal B
    Vaccine; 2014 May; 32(23):2712-21. PubMed ID: 24631092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.